Al-Tabakha Moawia M, Sameer Farah Tariq, Saeed Mai Hafiz, Batran Rahaf Montaser, Abouhegazy Nada Tarek, Farajallah Alaa A
Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates.
Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates.
J Pharm Bioallied Sci. 2018 Jan-Mar;10(1):1-6. doi: 10.4103/jpbs.JPBS_242_17.
Bloodletting cupping therapy (Hijama) is a traditional alternative medicine practiced in different cultures. Claims about the therapeutic efficacy of Hijama in hypertension are contradictory. The aim of this project was to determine if Hijama therapy is beneficial in the treatment of patients with hypertension.
In this retrospective study, 60 files for patients treated for hypertension, aged 40-60 years and whose systolic blood pressure (SBP) is at least 140mm Hg, were used. The data from 30 patient files were obtained from three licensed Hijama centers (study group), whereas data from the rest of 30 patient files were collected from a hospital (control group). The data from Hijama centers included age, date of Hijama therapy, and blood pressure measured before each Hijama session. Both diastolic blood pressure (DBP) and SBP data were obtained over 3-month period.
The results showed a significant reduction in SBP ( value < 0.01) over three sessions of wet cupping (from 149.2 to 130.8mm Hg), but this was not significant for DBP over three sessions ( = 0.074). The study also found that the mean SBP in the study group was 9.6mm Hg less than that in the control group (130.8 vs. 140.4mm Hg, = 0.019), whereas there was no significant difference in DBP between the study group and the control group (87.0 vs. 86.0mm Hg, = 0.75).
Our study shows clear relationship between Hijama and the reduction and control of SBP in patients with hypertension. Therefore, Hijama can be used as an adjunct to conventional therapy, which may allow downtitration of given doses of antihypertensive drugs. The possible association of SBP reduction by Hijama and pain reduction needs an investigation.
放血拔罐疗法（希贾马疗法）是一种在不同文化中施行的传统替代医学。关于希贾马疗法对高血压治疗效果的说法相互矛盾。本项目的目的是确定希贾马疗法对高血压患者的治疗是否有益。
在这项回顾性研究中，使用了60份年龄在40 - 60岁、收缩压至少为140mmHg的高血压患者治疗档案。30份患者档案的数据来自三个有执照的希贾马中心（研究组），而其余30份患者档案的数据则从一家医院收集（对照组）。希贾马中心的数据包括年龄、希贾马治疗日期以及每次希贾马治疗前测量的血压。舒张压（DBP）和收缩压（SBP）数据均在3个月期间获取。
结果显示，经过三次湿拔罐治疗后，收缩压显著降低（P值<0.01）（从149.2降至130.8mmHg），但三次治疗期间舒张压的降低不显著（P = .074）。该研究还发现，研究组的平均收缩压比对照组低9.6mmHg（130.8对140.4mmHg，P = .019），而研究组与对照组之间的舒张压无显著差异（87.0对86.0mmHg，P = .75）。
我们的研究表明希贾马疗法与高血压患者收缩压的降低和控制之间存在明确关系。因此，希贾马疗法可作为传统治疗的辅助手段，这可能允许减少给定剂量的降压药。希贾马疗法导致收缩压降低与疼痛减轻之间的可能关联需要进一步研究。
